|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 209/94 | (2006.01) |
| C07D 401/06 | (2006.01) | ||
| C07D 403/06 | (2006.01) | ||
| A61K 31/403 | (2006.01) | ||
| A61K 31/4439 | (2006.01) | ||
| A61P 5/26 | (2006.01) | ||
| A61P 19/10 | (2006.01) | ||
| A61P 21/00 | (2006.01) |
| (11) | Number of the document | 2297100 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09747531.3 |
| Date of filing the European patent application | 2009-05-14 | |
| (97) | Date of publication of the European application | 2011-03-23 |
| (45) | Date of publication and mention of the grant of the patent | 2012-10-31 |
| (46) | Date of publication of the claims translation | 2013-02-25 |
| (86) | Number | PCT/US2009/043875 |
| Date | 2009-05-14 |
| (87) | Number | WO 2009/140448 |
| Date | 2009-11-19 |
| (30) | Number | Date | Country code |
| 53722 | 2008-05-16 | US |
| (72) |
JADHAV, Prabhakar, Kondaji, US
KRISHNAN, Venkatesh, US
KIM, Euibong, Jemes, US
|
| (73) |
Eli Lilly & Company,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Tetrahidrociklopenta[b]indolo androgeno receptoriaus moduliatoriai |
| TETRAHYDROCYCLOPENTA[B]INDOLE ANDROGEN RECEPTOR MODULATORS |
| Payment date | Validity (years) | Amount | |
| 2025-04-23 | 17 | 347.00 EUR |
| 2026-05-14 |